[3] Triple-negative breast cancer (TNBC), which is clinically defined by the absence of expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), contributes to an approximate 15–20% of all breast cancer cases. The gene discussed is PGR; the disease is breast carcinoma.